BWX Technologies Inc is a specialty manufacturer and service provider of nuclear components, operating in two segments: Government Operations and Commercial Operations. The Government Operations segment produces naval nuclear reactors and fuel for the U.S. Naval Nuclear Propulsion Program, while the Commercial Operations segment designs and manufactures commercial nuclear steam generators, heat exchangers, pressure vessels, reactor components, and other auxiliary equipment, including containers for the storage of spent nuclear fuel and other high-level nuclear waste. The majority of the company's revenue comes from Government Operations, with sales principally in the United States, Canada, and other regions.
Last trade$119.02
Day change+$1.93 (+1.65%)
Day range$114.41 – $122.30
Volume843,852
Market cap$10.73B
OpenXNYS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$10.73B
Price / earnings
28.63×
Price / book
7.56×
Price / sales
2.98×
EV / sales
3.38×
EV / EBITDA
25.51×
Profitability
Earnings per share
$4.09
Return on assets
7.88%
Return on equity
26.42%
Dividend yield
0.91%
Liquidity and leverage
Debt / equity
1.43×
Current ratio
1.9×
Quick ratio
0.98×
Cash ratio
0.6×
Cash flow
Price / cash flow
18.54×
Price / free cash flow
28.81×
Free cash flow
$372.32M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for BWXT, quarterly periods
Line item
Q3 FY2026 Sep 30, 2026
Q2 FY2026 Jun 30, 2026
Q1 FY2026 Mar 31, 2026
Q4 FY2025 Dec 31, 2025
Q3 FY2025 Sep 30, 2025
Q2 FY2025 Jun 30, 2025
Q1 FY2025 Mar 31, 2025
Q4 FY2024 Dec 31, 2024
Revenue
$952.97M
$901.63M
$860.22M
$885.84M
$866.29M
$764.04M
$682.26M
$746.27M
Cost of revenue
$725.83M
$699.32M
$662.85M
$698.57M
$677.29M
$572.64M
$517.07M
$571.89M
Gross profit
$227.14M
$202.31M
$197.37M
$187.28M
$188.99M
$191.4M
$165.19M
$174.37M
Selling, general and administrative
$117.22M
$108.43M
$108.02M
$110.53M
$93.38M
$102.94M
$87.57M
$90.69M
Research and development
$3.83M
$4.17M
$4.1M
$3.81M
$3.48M
$4.57M
$2.01M
$2.64M
Total operating expenses
$121.05M
$112.6M
$112.24M
$114.34M
$96.86M
$107.52M
$85.15M
$93.33M
Operating income
$106.09M
$89.71M
$85.13M
$72.94M
$92.13M
$83.88M
$80.04M
$81.04M
Interest expense
-$5.11M
-$5.28M
-$4.73M
-$10.45M
-$14.02M
-$11.74M
-$7.99M
-$9.29M
Income before taxes
$131.9M
$113.59M
$107.32M
$100.98M
$107.57M
$97.76M
$91.82M
$78.09M
Income taxes
$29.92M
$24.5M
$16.13M
$7.29M
$25.38M
$19.3M
$16.29M
$7.01M
Net income
$101.98M
$89.1M
$91.19M
$93.68M
$82.19M
$78.46M
$75.53M
$71.08M
Net income attributable to common shareholders
$101.71M
$89.01M
$91.07M
$92.99M
$82.11M
$78.39M
$75.46M
$71.02M
EBITDA
$139.61M
$121.07M
$114.26M
$102.5M
$120.59M
$111.15M
$99.52M
$103.48M
Basic earnings per share
$1.11
$0.97
$0.99
$1.02
$0.90
$0.86
$0.82
$0.78
Diluted earnings per share
$1.11
$0.97
$0.99
$1.01
$0.89
$0.85
$0.82
$0.77
Recent news
Company coverage with links to the original publishers.
As Q3 earnings season winds down, BWX Technologies, Johnson & Johnson, and UnitedHealth Group have emerged as winners by raising their FY26 guidance. BWXT benefited from strong commercial nuclear demand with 18% revenue growth, JNJ posted solid results with 5.9% sales growth, and UNH showed improving cost trends with a declining medical care ratio. All three companies' raised outlooks reflect improving business fundamentals and management confidence.
BWX Technologies reported Q3 2026 revenue of $953 million, up 10% year-over-year, with strong growth driven by defense uranium programs and commercial nuclear operations. The company is expanding manufacturing capacity in Tennessee and Canada to meet surging demand for defense components and small modular reactors, while raising free cash flow guidance to $350-360 million. Management expects high single-digit to low double-digit EBITDA growth in 2027.
BWX Technologies (BWXT) is highlighted as a potential growth investment despite holding a #3 (Hold) Zacks Rank. The specialty nuclear components manufacturer shows strong fundamentals with a B Growth Style Score, forecasting 18.7% year-over-year earnings growth for fiscal 2026. Three analysts raised earnings estimates in the last 60 days, and the company maintains a +13.1% average earnings surprise.
Nuclear energy stocks have experienced significant sell-offs in 2026, with Oklo down 86% and BWX Technologies down 45% from their highs. The article compares the two companies, concluding that BWX Technologies is the better buy due to its established military contracts, diversified revenue streams, and commercial opportunities in small modular reactors. Oklo, while promising, remains pre-revenue with no NRC-approved reactor design and is years away from operations.
BWX Technologies (BWXT) expects high-single-digit revenue growth in 2027 with faster adjusted EBITDA and earnings growth. Q3 revenue of $952.79M missed estimates but adjusted EPS beat expectations. The company is strengthening government margins through improved naval nuclear manufacturing, expanding commercial operations capacity by 50%, and advancing advanced nuclear programs including microreactor technology and TRISO fuel production.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
Declared upcoming dividend$0.27 per share
Declared
Oct 28, 2026
Ex-dividend
Nov 19, 2026
Pay date
Dec 10, 2026
Ex-dividend
Amount / share
Pay date
Type
Aug 18, 2026
$0.27
Sep 4, 2026
recurring
May 19, 2026
$0.27
Jun 5, 2026
recurring
Mar 11, 2026
$0.27
Mar 27, 2026
recurring
Nov 19, 2025
$0.25
Dec 10, 2025
recurring
Aug 18, 2025
$0.25
Sep 5, 2025
recurring
Stock splits
Historical share-structure events and their execution dates.